DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Chan HLY, Fung S, Seto WK. et al; GS-US-320-0110 Investigators.
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
Lancet Gastroenterol Hepatol 2016;
1 (03) 185-195
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.